Picture of Semnur Pharmaceuticals logo

SMNR Semnur Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapValue Trap

Brief: Denali Capital Acquisition Corp. Announces Shareholder Approval Of Extension Of Deadline To Complete Business Combination

Oct 11 (Reuters) - Denali Capital Acquisition Corp
 DECA.O :
    * DENALI CAPITAL ACQUISITION CORP. ANNOUNCES SHAREHOLDER
APPROVAL
OF EXTENSION OF DEADLINE TO COMPLETE BUSINESS COMBINATION
    * DENALI CAPITAL ACQUISITION CORP - TO EXTEND DATE BY WHICH
COMPANY MUST CONSUMMATE AN INITIAL BUSINESS COMBINATION TO JULY
11, 2024

Source text for Eikon:  ID:nPn5WLSWga 
Further company coverage:  DECA.O 

 ((Reuters.briefs@thomsonreuters.com;))

Recent news on Semnur Pharmaceuticals

See all news